Nombre de documents

14

CV de David Devos


Article dans une revue14 documents

  • Sophie Drapier, Alexandre Eusebio, Bertrand Degos, Marc Vérin, Franck Durif, et al.. Quality of life in Parkinson’s disease improved by apomorphine pump: the OPTIPUMP cohort study. Journal of Neurology, Springer Verlag, 2016, pp.1--9. <10.1007/s00415-016-8106-3>. <hal-01301510>
  • G. Grolez, C. Moreau, V. Danel-Brunaud, C. Delmaire, R. Lopes, et al.. The value of magnetic resonance imaging as a biomarker for amyotrophic lateral sclerosis: a systematic review. BMC Neurology, BioMed Central, 2016, 16 (1), pp.155. <10.1186/s12883-016-0672-6>. <hal-01357813>
  • Hélène Blasco, Jerzy Blaszczynski, Billaut Jean-Charles, Lydie Nadal-Desbarats, Pierre-Francois Pradat, et al.. Comparative analysis of targeted metabolomics : dominance-based rough set approach versus orthogonal partial least square-discriminant analysis. Journal of Biomedical Informatics, Elsevier, 2015, 53, pp.291-299. <10.1016/j.jbi.2014.12.001>. <hal-01233551>
  • Jean-Christophe Corvol, David Devos, Jean-Sébastien Hulot, Lucette Lacomblez. Clinical implications of neuropharmacogenetics. Revue Neurologique, Elsevier Masson, 2015, 171 (6-7), pp.482-497. <10.1016/j.neurol.2015.04.003>. <hal-01166982>
  • Céline Tard, Arnaud Delval, David Devos, Renaud Lopes, Pierre Lenfant, et al.. Brain metabolic abnormalities during gait with freezing in Parkinson’s disease. Neuroscience, Elsevier - International Brain Research Organization, 2015, 307, pp.281-301. <10.1016/j.neuroscience.2015.08.063>. <hal-01195740>
  • Caroline Moreau, Sayah Meguig, Jean-Christophe Corvol, Julien Labreuche, Francis Vasseur, et al.. Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease.. Brain - A Journal of Neurology , Oxford University Press (OUP), 2015, 138 (5), pp.1271-1283. <10.1093/brain/awv063>. <hal-01137943>
  • Guillaume Grolez, Caroline Moreau, Bernard Sablonnière, Guillaume Garçon, Jean-Christophe Devedjian, et al.. Ceruloplasmin activity and iron chelation treatment of patients with Parkinson’s disease. BMC Neurology, BioMed Central, 2015, 15 (1), pp.74. <10.1186/s12883-015-0331-3>. <inserm-01264480>
  • Cyril Mignot, Emmanuelle Apartis, Alexandra Durr, Charles Marques Lourenço, Perrine Charles, et al.. Phenotypic variability in ARCA2 and identification of a core ataxic phenotype with slow progression.. Orphanet Journal of Rare Diseases, BioMed Central, 2013, 8 (1), pp.173. <10.1186/1750-1172-8-173>. <inserm-00907850>
  • Caroline Moreau, Arnaud Delval, Luc Defebvre, Kathy Dujardin, Alain Duhamel, et al.. Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial.. Lancet Neurology, Elsevier, 2012, 11 (7), pp.589-96. <10.1016/S1474-4422(12)70106-0>. <hal-01133862>
  • Noémie Ligot, Pierre Krystkowiak, Clémence Simonin, Serge Goldman, Philippe Peigneux, et al.. External globus pallidus stimulation modulates brain connectivity in Huntington's disease.. Journal of Cerebral Blood Flow and Metabolism, Nature Publishing Group, 2011, 31 (1), pp.41-6. <10.1038/jcbfm.2010.186>. <hal-00795751>
  • David Devos. Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease.. Movement Disorders, Wiley, 2009, 24 (7), pp.993-1000. <10.1002/mds.22450>. <inserm-00410554>
  • David Devos, Kathy Dujardin, Isabelle Poirot, Caroline Moreau, Olivier Cottencin, et al.. Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study.. Movement Disorders, Wiley, 2008, 23 (6), pp.850-7. <10.1002/mds.21966>. <hal-00336977>
  • Melissa Tir, David Devos, Serge Blond, Gustavo Touzet, Nicolas Reyns, et al.. Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single-center cohort of parkinsonian patients.. Neurosurgery, Lippincott, Williams & Wilkins, 2007, 61 (2), pp.297-304; discussion 304-5. <10.1227/01.NEU.0000285347.50028.B9>. <hal-00336994>
  • Kathy Dujardin, David Devos, Stéphane Duhem, Alain Destée, Rose-Marie Marié, et al.. Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson's disease.. Deutsche Zeitschrift für Nervenheilkunde / Deutsche Zeitschrift f ur Nervenheilkunde, 2006, 253 (9), pp.1154-9. <10.1007/s00415-006-0175-2>. <inserm-00391624>